Quick Summary
• Auxilium Biotechnologies, a clinical-stage biotechnology company, has bioprinted kidney and liver tissue aboard the International Space Station (ISS), marking the first time either tissue type has been manufactured in orbit. The tissues, along with cartilage and 28 nerve repair implants, were produced using the company’s AMP-1 bioprinting platform during Mission AXLM-3, which launched on SpaceX-34…
Additional Context
Auxilium Biotechnologies, a clinical-stage biotechnology company, has bioprinted kidney and liver tissue aboard the International Space Station (ISS), marking the first time either tissue type has been manufactured in orbit. The tissues, along with cartilage and 28 nerve repair implants, were produced using the company’s AMP-1 bioprinting platform during Mission AXLM-3, which launched on SpaceX-34 and splashed down off the California coast on June 17, 2026.
According to Auxilium, the mission marks the first time three distinct tissue types have been manufactured during a single spaceflight, and the first time a single manufacturing platform has produced both living tissue and implantable medical devices on the same flight. The kidney and liver tissues were made using cells and tissue desi